Newsletters
Newsletters published on
May 18, 2020
In this newsletter, Dr. Shaji Kumar addresses how clinicians at his institution are managing patients' care during the COVID-19 pandemic.
Newsletters published on
March 23, 2020
In this newsletter, Dr. Shah discusses the toxicities that need to be considered with regard to agents targeting B-cell maturation antigen (BCMA), including cytokine release syndrome (CRS).
Newsletters published on
March 23, 2020
In this newsletter, Dr. Orlowski discusses the clinical trial data for therapies that target BCMA, which is expressed in most cases of multiple myeloma.
Newsletters published on
March 23, 2020
In this newsletter, Dr. Munshi explains why BCMA has become increasingly important as a target of therapy in multiple myeloma, focusing on the unmet need for novel treatments.
Results 1 - 4 of 4